Abbott Enterprise Value vs Operating Margin Analysis

ABT Stock

USD 108.89 0.22 0.20%

Abbott Laboratories financial indicator trend analysis is way more than just evaluating Abbott Laboratories prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Abbott Laboratories is a good investment. Please check the relationship between Abbott Laboratories Enterprise Value and its Operating Profit Margin accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Enterprise Value vs Operating Profit Margin

Enterprise Value vs Operating Margin Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Abbott Laboratories Enterprise Value account and Operating Margin. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Abbott Laboratories' Enterprise Value and Operating Margin is 0.17. Overlapping area represents the amount of variation of Enterprise Value that can explain the historical movement of Operating Margin in the same time period over historical financial statements of Abbott Laboratories, assuming nothing else is changed. The correlation between historical values of Abbott Laboratories' Enterprise Value and Operating Margin is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Enterprise Value of Abbott Laboratories are associated (or correlated) with its Operating Margin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Margin has no effect on the direction of Enterprise Value i.e., Abbott Laboratories' Enterprise Value and Operating Margin go up and down completely randomly.

Correlation Coefficient

0.17

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Enterprise Value

Enterprise Value (or EV) is usually referred to as Abbott Laboratories theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Abbott Laboratories debt, but would also pocket its cash. Enterprise Value is more accurate representation of Abbott Laboratories value than its market capitalization because it takes into account all of Abbott Laboratories existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Operating Profit Margin

Most indicators from Abbott Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Abbott Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.At this time, Abbott Laboratories' Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 19.89 in 2024, whereas Tax Provision is likely to drop slightly above 949.8 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	24.5B	24.5B	22.1B	12.5B
Total Revenue	43.1B	43.7B	40.1B	22.2B

Gross Profit Total Revenue

Abbott Laboratories fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Accounts Payable	Current Deferred Revenue	Common Stock Total Equity	Short Term Investments
Total Assets		0.87	0.69	0.77	0.75	0.92	0.77	0.61	0.49	0.82	0.23	0.45	0.84	0.3	0.89	0.61	0.15	-0.05	0.97	0.41	0.74	-0.18	0.63	-0.3	0.67	-0.06
Short Long Term Debt Total	0.87		0.45	0.44	0.53	0.65	0.79	0.4	0.68	0.71	0.18	0.6	0.6	0.22	0.99	0.37	-0.03	0.0	0.95	0.18	0.68	-0.36	0.42	-0.29	0.51	-0.16
Other Current Liab	0.69	0.45		0.9	0.78	0.8	0.41	0.69	0.24	0.69	0.08	0.29	0.9	-0.13	0.47	0.76	0.47	-0.42	0.67	0.65	0.67	0.19	0.67	-0.07	0.55	0.17
Total Current Liabilities	0.77	0.44	0.9		0.68	0.86	0.37	0.62	0.27	0.58	0.13	0.32	0.93	0.02	0.46	0.62	0.57	-0.37	0.69	0.51	0.73	0.34	0.53	-0.16	0.44	0.18
Total Stockholder Equity	0.75	0.53	0.78	0.68		0.84	0.55	0.93	0.2	0.92	0.19	0.17	0.68	-0.06	0.54	0.94	0.1	0.1	0.65	0.82	0.49	-0.06	0.89	-0.36	0.94	-0.06
Property Plant And Equipment Net	0.92	0.65	0.8	0.86	0.84		0.61	0.75	0.33	0.81	0.21	0.31	0.86	0.21	0.67	0.78	0.22	-0.08	0.82	0.62	0.69	-0.06	0.74	-0.24	0.74	-0.03
Net Debt	0.77	0.79	0.41	0.37	0.55	0.61		0.29	0.09	0.82	0.35	0.03	0.52	0.42	0.85	0.4	-0.17	-0.01	0.81	0.13	0.26	-0.43	0.49	-0.14	0.61	-0.2
Retained Earnings	0.61	0.4	0.69	0.62	0.93	0.75	0.29		0.31	0.76	0.1	0.27	0.56	-0.29	0.37	0.91	0.13	0.16	0.5	0.85	0.5	0.1	0.8	-0.42	0.86	-0.09
Cash	0.49	0.68	0.24	0.27	0.2	0.33	0.09	0.31		0.17	-0.12	0.95	0.35	-0.14	0.59	0.13	0.16	0.0	0.57	0.13	0.79	-0.08	0.1	-0.31	0.11	-0.02
Non Current Assets Total	0.82	0.71	0.69	0.58	0.92	0.81	0.82	0.76	0.17		0.29	0.08	0.66	0.15	0.74	0.83	-0.09	0.05	0.79	0.64	0.39	-0.28	0.86	-0.27	0.93	-0.25
Non Currrent Assets Other	0.23	0.18	0.08	0.13	0.19	0.21	0.35	0.1	-0.12	0.29		-0.17	0.13	0.25	0.21	0.17	-0.15	0.07	0.21	0.03	-0.05	-0.08	0.24	0.1	0.26	-0.16
Cash And Short Term Investments	0.45	0.6	0.29	0.32	0.17	0.31	0.03	0.27	0.95	0.08	-0.17		0.38	-0.23	0.52	0.07	0.37	-0.01	0.52	0.06	0.87	0.06	-0.01	-0.32	0.0	0.3
Net Receivables	0.84	0.6	0.9	0.93	0.68	0.86	0.52	0.56	0.35	0.66	0.13	0.38		0.19	0.63	0.64	0.4	-0.32	0.81	0.51	0.76	0.08	0.61	-0.02	0.48	0.14
Common Stock Shares Outstanding	0.3	0.22	-0.13	0.02	-0.06	0.21	0.42	-0.29	-0.14	0.15	0.25	-0.23	0.19		0.3	-0.04	-0.48	0.15	0.26	-0.07	-0.12	-0.64	0.21	0.42	0.08	-0.31
Non Current Liabilities Total	0.89	0.99	0.47	0.46	0.54	0.67	0.85	0.37	0.59	0.74	0.21	0.52	0.63	0.3		0.38	-0.05	-0.01	0.96	0.17	0.64	-0.41	0.46	-0.23	0.53	-0.16
Inventory	0.61	0.37	0.76	0.62	0.94	0.78	0.4	0.91	0.13	0.83	0.17	0.07	0.64	-0.04	0.38		0.0	0.11	0.51	0.92	0.39	-0.11	0.95	-0.12	0.9	-0.15
Other Current Assets	0.15	-0.03	0.47	0.57	0.1	0.22	-0.17	0.13	0.16	-0.09	-0.15	0.37	0.4	-0.48	-0.05	0.0		-0.42	0.14	-0.03	0.56	0.8	-0.21	-0.31	-0.22	0.67
Other Stockholder Equity	-0.05	0.0	-0.42	-0.37	0.1	-0.08	-0.01	0.16	0.0	0.05	0.07	-0.01	-0.32	0.15	-0.01	0.11	-0.42		-0.13	0.1	-0.18	-0.33	0.15	-0.11	0.28	-0.05
Total Liab	0.97	0.95	0.67	0.69	0.65	0.82	0.81	0.5	0.57	0.79	0.21	0.52	0.81	0.26	0.96	0.51	0.14	-0.13		0.3	0.75	-0.23	0.54	-0.24	0.58	-0.07
Property Plant And Equipment Gross	0.41	0.18	0.65	0.51	0.82	0.62	0.13	0.85	0.13	0.64	0.03	0.06	0.51	-0.07	0.17	0.92	-0.03	0.1	0.3		0.3	-0.07	0.87	-0.04	0.78	-0.18
Total Current Assets	0.74	0.68	0.67	0.73	0.49	0.69	0.26	0.5	0.79	0.39	-0.05	0.87	0.76	-0.12	0.64	0.39	0.56	-0.18	0.75	0.3		0.17	0.28	-0.31	0.25	0.34
Short Term Debt	-0.18	-0.36	0.19	0.34	-0.06	-0.06	-0.43	0.1	-0.08	-0.28	-0.08	0.06	0.08	-0.64	-0.41	-0.11	0.8	-0.33	-0.23	-0.07	0.17		-0.34	-0.3	-0.3	0.44
Accounts Payable	0.63	0.42	0.67	0.53	0.89	0.74	0.49	0.8	0.1	0.86	0.24	-0.01	0.61	0.21	0.46	0.95	-0.21	0.15	0.54	0.87	0.28	-0.34		-0.02	0.92	-0.32
Current Deferred Revenue	-0.3	-0.29	-0.07	-0.16	-0.36	-0.24	-0.14	-0.42	-0.31	-0.27	0.1	-0.32	-0.02	0.42	-0.23	-0.12	-0.31	-0.11	-0.24	-0.04	-0.31	-0.3	-0.02		-0.32	-0.07
Common Stock Total Equity	0.67	0.51	0.55	0.44	0.94	0.74	0.61	0.86	0.11	0.93	0.26	0.0	0.48	0.08	0.53	0.9	-0.22	0.28	0.58	0.78	0.25	-0.3	0.92	-0.32		-0.33
Short Term Investments	-0.06	-0.16	0.17	0.18	-0.06	-0.03	-0.2	-0.09	-0.02	-0.25	-0.16	0.3	0.14	-0.31	-0.16	-0.15	0.67	-0.05	-0.07	-0.18	0.34	0.44	-0.32	-0.07	-0.33

Click cells to compare fundamentals

Abbott Laboratories Account Relationship Matchups

Abbott Laboratories fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	67.9B	72.5B	75.2B	74.4B	73.2B	36.9B
Short Long Term Debt Total	18.9B	19.6B	19.0B	17.7B	15.9B	9.8B
Other Current Liab	6.1B	7.7B	7.9B	8.6B	7.7B	8.1B
Total Current Liabilities	10.9B	11.9B	13.1B	15.5B	13.8B	8.3B
Total Stockholder Equity	31.1B	32.8B	35.8B	36.7B	38.6B	40.5B
Property Plant And Equipment Net	8.0B	9.0B	9.0B	9.2B	11.3B	6.2B
Net Debt	15.0B	12.8B	9.2B	7.8B	9.0B	6.1B
Retained Earnings	25.8B	27.6B	31.5B	35.3B	37.6B	39.4B
Cash	3.9B	6.8B	9.8B	9.9B	6.9B	3.7B
Non Current Assets Total	52.2B	52.1B	51.0B	49.2B	50.5B	53.1B
Non Currrent Assets Other	52.2B	3.7B	5.2B	6.0B	6.0B	3.1B
Cash And Short Term Investments	4.1B	7.1B	10.2B	10.2B	7.3B	4.3B
Net Receivables	5.4B	6.4B	6.5B	8.9B	6.6B	3.9B
Common Stock Shares Outstanding	1.8B	1.8B	1.8B	1.8B	1.8B	1.3B
Liabilities And Stockholders Equity	67.9B	72.5B	75.2B	74.4B	73.2B	36.9B
Non Current Liabilities Total	25.7B	27.6B	26.1B	22.0B	20.5B	11.7B
Inventory	4.3B	5.0B	5.2B	6.2B	6.6B	6.9B
Other Current Assets	1.8B	1.9B	2.3B	2.7B	2.3B	2.2B
Other Stockholder Equity	(10.1B)	(10.0B)	(11.8B)	(15.2B)	(16.0B)	(16.8B)
Total Liab	36.6B	39.5B	39.2B	37.5B	34.4B	20.0B
Property Plant And Equipment Gross	8.0B	9.0B	19.4B	20.2B	21.9B	23.0B
Total Current Assets	15.7B	20.4B	24.2B	25.2B	22.7B	13.3B
Accumulated Other Comprehensive Income	(8.5B)	(8.9B)	(8.4B)	(8.1B)	(7.8B)	(7.4B)
Short Term Debt	207M	1.5B	220M	754M	2.3B	2.0B
Accounts Payable	3.3B	3.9B	4.4B	4.6B	4.3B	4.5B
Common Stock Total Equity	23.9B	24.1B	24.5B	24.7B	28.4B	29.8B
Short Term Investments	280M	310M	450M	288M	383M	757.2M
Common Stock	23.9B	24.1B	24.5B	24.7B	24.9B	23.6B
Intangible Assets	17.0B	14.8B	12.7B	10.5B	8.8B	9.1B
Other Liab	8.3B	8.2B	7.8B	6.6B	7.6B	5.7B
Other Assets	2.4B	2.8B	4.1B	4.9B	5.7B	5.9B
Long Term Debt	16.7B	18.5B	17.3B	14.5B	13.6B	12.0B
Treasury Stock	(10.0B)	(10.1B)	(10.0B)	(11.8B)	(10.6B)	(10.1B)
Property Plant Equipment	8.0B	9.0B	9.0B	9.2B	10.5B	7.7B
Good Will	23.2B	23.7B	23.2B	22.8B	23.7B	15.5B
Net Tangible Assets	(70M)	3.4B	(2.2B)	11.0B	9.9B	10.4B
Noncontrolling Interest In Consolidated Entity	198M	213M	219M	222M	251.9M	163.8M
Retained Earnings Total Equity	25.8B	27.6B	31.5B	35.3B	40.5B	27.2B
Long Term Debt Total	16.7B	18.5B	17.3B	14.5B	16.7B	15.8B

Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving against Abbott Stock

0.49

EHAB

Enhabit Financial Report 14th of May 2024

Pair Corr

The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.

The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:

How To Invest In Abbott

Details

Is Abbott Stock a good investment?

Details

What is Abbott Laboratories' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Global Correlations Find global opportunities by holding instruments from different markets
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories

Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.55

Dividend Share

2.08

Earnings Share

3.26

Revenue Per Share

23.051

Quarterly Revenue Growth

0.015

The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Abbott Enterprise Value vs Operating Margin Analysis

Enterprise Value vs Operating Profit Margin

Enterprise Value vs Operating Margin Correlation Analysis

Correlation Coefficient

Enterprise Value

Operating Profit Margin

Abbott Laboratories fundamental ratios Correlations

Abbott Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Abbott Laboratories fundamental ratios Accounts

Pair Trading with Abbott Laboratories

Moving against Abbott Stock

Complementary Tools for Abbott Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.97	Total Assets
Total Liab	+ 0.96	Non Current Liabilities Total
Total Liab	+ 0.95	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.95	Cash
Accounts Payable	+ 0.95	Inventory

Short Term Debt	- 0.64	Common Stock Shares Outstanding
Other Current Assets	- 0.48	Common Stock Shares Outstanding
Short Term Debt	- 0.43	Net Debt
Other Stockholder Equity	- 0.42	Other Current Assets
Current Deferred Revenue	- 0.42	Retained Earnings
Other Stockholder Equity	- 0.42	Other Current Liab